Litian Pictures Holdings Limited (09958 HK) has unveiled a three-part capital action comprising an authorised share-capital expansion, a sizeable non-underwritten rights issue and a post-rights board-lot adjustment.
Key Transaction Terms • Authorised capital: proposed increase to HK$40.00 million from HK$5.00 million through the creation of 3.50 billion new shares (HK$0.01 par). • Rights issue: up to 2.00 billion new shares on a 4-for-1 basis at HK$0.095 each, implying gross proceeds of up to HK$190.00 million and net proceeds of about HK$188.00 million. • Pricing: 22.13% discount to the 27 Aug 2026 close (HK$0.122) and 5.57% below the theoretical ex-rights price of HK$0.1006; dilution impact estimated at 18.21%, within Listing Rule limits (<25%). • Subscription mechanics: no excess application, no minimum subscription; offer limited to qualifying shareholders. Any unsubscribed entitlements will be placed to independent investors by DaoKou Securities under compensatory arrangements; unsold shares will be cancelled, shrinking deal size. • Post-deal share count: enlarged to 2.50 billion shares versus 500 million currently, assuming full take-up.
Timetable Highlights • Record date: 23 Oct 2026 (books close 16–23 Oct). • Nil-paid trading: 28 Oct–4 Nov 2026. • Acceptance deadline: 9 Nov 2026. • Placing window for unsubscribed shares: 19–26 Nov 2026. • Results announcement: 2 Dec 2026; fully-paid trading begins 4 Dec 2026. • Extraordinary General Meeting to approve the proposals: 8 Oct 2026.
Use of Proceeds (net HK$188.00 million) 1. Debt and payables repayment – HK$95.00 million (50%) – Settlement of overdue payables to three suppliers totalling RMB75.54 million and short-term loans of HK$8.70 million. 2. Content development – HK$57.00 million (30%) – Production of roughly 300 short drama projects budgeted at RMB60.00 million in aggregate. 3. General working capital – HK$38.00 million (20%) – Operating costs through June 2027, including RMB10.00 million salaries, RMB5.00 million professional fees and RMB18.00 million marketing spend.
Strategic Rationale Management cites the need to reinforce liquidity and fund content expansion amid net current liabilities of RMB528.10 million and a current ratio of 0.2x as at 31 Dec 2025. Total bank and other loans stood at RMB151.20 million, including RMB138.90 million in producer loans bearing 15% interest. The rights issue, following two placings that raised a combined HK$24.33 million in 2026, is viewed as a more shareholder-friendly alternative to further debt or placings, enabling existing investors to maintain proportional ownership.
Board-Lot Change Effective 9 Oct 2026, the trading lot will increase from 1,000 to 10,000 shares, lifting the post-ex-rights lot value to approximately HK$1,006 (based on theoretical ex-rights price). A designated broker will provide odd-lot matching; existing certificates remain valid.
Governance and Regulatory Matters • As the rights issue expands issued capital by 400%, Rule 7.19A/7.27A of the Hong Kong Listing Rules requires approval from independent shareholders; all executive directors must abstain from voting. • An Independent Board Committee will evaluate the deal, with an independent financial adviser to be appointed. • The rights shares’ listing approval from the Stock Exchange is a key condition; failure to satisfy conditions by 27 Nov 2026 will abort the offer.
Risk Reminder The offer is non-underwritten; undersubscription will proportionally reduce funds raised and dilute non-participating holders. Trading in existing or nil-paid rights shares before deal completion is subject to execution risk.